Noticias de Eulerpool Vascular Biogenics

Vascular Biogenics Noticias de Acciones

Vascular Biogenics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Vascular Biogenics.

• 8 de marzo ·

  Thefly.com
  VBL announces completion of enrollment in OVAL Phase 3 trial of ofra-vec
• 3 de marzo ·

  Yahoo
  VBL Therapeutics to Participate at March Investor Conferences
• 2 de febrero ·

  Yahoo
  VBL Therapeutics to Participate in the Guggenheim Oncology Conference and the 2022 BIO CEO & Investor Conference
• 27 de enero ·

  CNBC
  Ackman takes a big stake in Netflix, excited about company's long-term prospects
• 21 de enero ·

  CNBC
  Markets are expected to remain on edge as the Fed meets in the week ahead
• 19 de enero ·

  Benzinga
  Stocks That Hit 52-Week Lows On Wednesday
• 18 de enero ·

  Thefly.com
  VBL Therapeutics appoints Matthew Trudeau as CCO
• 10 de enero ·

  CNBC
  Joe Manchin's former aides gain influential lobbying clients as their ex-boss battles Biden's agenda